1
|
Lin SW, Abnet CC, Freedman ND, et al:
Measuring telomere length for the early detection of precursor
lesions of esophageal squamous cell carcinoma. BMC Cancer.
13:5782013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wu C, Li M, Hu C and Duan H: Prognostic
role of microRNA polymorphisms in patients with advanced esophageal
squamous cell carcinoma receiving platinum-based chemotherapy.
Cancer Chemother Pharmacol. 73:335–341. 2014. View Article : Google Scholar
|
3
|
Ku GY and Ilson DH: Adjuvant
(postoperative) therapy for esophageal cancer. Thorac Surg Clin.
23:525–533. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Liu L, Zuo LF and Guo JW: Reversal of
multidrug resistance by the anti-malaria drug artesunate in the
esophageal cancer Eca109/ABCG2 cell line. Oncol Lett. 6:1475–1481.
2013.PubMed/NCBI
|
5
|
Liu R, Yang M, Meng Y, et al:
Tumor-suppressive function of miR-139–5p in esophageal squamous
cell carcinoma. PLoS One. 8:e770682013. View Article : Google Scholar
|
6
|
Marks J, Rice DC and Swisher SG: Salvage
esophagectomy in the management of recurrent or persistent
esophageal carcinoma. Thorac Surg Clin. 23:559–567. 2013.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Migita K, Sho M, Shimada K, et al:
Significant involvement of herpesvirus entry mediator in human
esophageal squamous cell carcinoma. Cancer. 120:808–817. 2014.
View Article : Google Scholar
|
8
|
Moghbeli M, Forghanifard MM, Aarabi A,
Mansourian A and Abbaszadegan MR: Clinicopathological sex-related
relevance of Musashi1 mRNA expression in esophageal squamous cell
carcinoma patients. Pathol Oncol Res. Oct 28–2013.(Epub ahead of
print).
|
9
|
Nurkin SJ, Nava HR, Yendamuri S, et al:
Outcomes of endoscopic resection for high-grade dysplasia and
esophageal cancer. Surg Endosc. 28:1090–1095. 2014. View Article : Google Scholar
|
10
|
Oze I, Matsuo K, Kawakita D, et al: Coffee
and green tea consumption is associated with upper aerodigestive
tract cancer in Japan. Int J Cancer. 135:391–400. 2014. View Article : Google Scholar
|
11
|
Paul S and Altorki N: Induction therapy
for esophageal cancer. Thorac Surg Clin. 23:499–507. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Murata K, Ito H, Yoshitomi H, et al:
Inhibition of miR-92a enhances fracture healing via promoting
angiogenesis in a model of stabilized fracture in young mice. J
Bone Miner Res. 29:316–326. 2014. View Article : Google Scholar
|
13
|
Menigatti M, Staiano T, Manser CN, et al:
Epigenetic silencing of monoallelically methylated miRNA loci in
precancerous colorectal lesions. Oncogenesis. 2:e562013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Guo L, Zhao Y, Zhang H, Yang S and Chen F:
Close association between paralogous multiple isomiRs and
paralogous/orthologues miRNA sequences implicates dominant sequence
selection across various animal species. Gene. 527:624–629. 2013.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen Y, Min L, Zhang X, et al: Decreased
miRNA-148a is associated with lymph node metastasis and poor
clinical outcomes and functions as a suppressor of tumor metastasis
in non-small cell lung cancer. Oncol Rep. 30:1832–1840.
2013.PubMed/NCBI
|
16
|
Edelstein LC, McKenzie SE, Shaw C, et al:
MicroRNAs in platelet production and activation. J Thromb Haemost.
11(Suppl 1): 340–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Gu J, Hu W, Wu J, et al: miRNA genes of an
invasive vector mosquito, Aedes albopictus. PLoS One. 8:e676382013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Anwar SL, Albat C, Krech T, et al:
Concordant hypermethylation of intergenic microRNA genes in human
hepatocellular carcinoma as new diagnostic and prognostic marker.
Int J Cancer. 133:660–670. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Biscontin A, Casara S, Cagnin S, et al:
New miRNA labeling method for bead-based quantification. BMC Mol
Biol. 11:442010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chen X, Huang Z, Chen D, Yang T and Liu G:
MicroRNA-27a is induced by leucine and contributes to
leucine-induced proliferation promotion in C2C12 cells. Int J Mol
Sci. 14:14076–14084. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
No authors listed. Update of the NCCN
guidelines for treatment of breast cancer. Oncology (Williston
Park). 11:199–220. 1997.
|
22
|
Zhang J, Lu Y, Yue X, et al: MiR-124
suppresses growth of human colorectal cancer by inhibiting STAT3.
PLoS One. 8:e703002013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Riedl CC, Slobod E, Jochelson M, et al:
Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic
Breast Cancer Patients Younger Than 40 Years. J Nucl Med.
55:1578–1583. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kaspi H, Chapnik E, Levy M, et al: Brief
report: miR-290–295 regulate embryonic stem cell differentiation
propensities by repressing Pax6. Stem Cells. 31:2266–2272. 2013.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Liao WT, Li TT, Wang ZG, et al:
microRNA-224 promotes cell proliferation and tumor growth in human
colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res.
19:4662–4672. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lu J and Bushel PR: Dynamic expression of
3′ UTRs revealed by Poisson hidden Markov modeling of RNA-Seq:
implications in gene expression profiling. Gene. 527:616–623. 2013.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Pincini A, Tornillo G, Orso F, et al:
Identification of p130Cas/ErbB2-dependent invasive signatures in
transformed mammary epithelial cells. Cell Cycle. 12:2409–2422.
2013. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Xu Q, He CY, Liu JW and Yuan Y:
Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis.
PLoS One. 8:e652082013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Wang X, Wang ZH, Wu YY, et al: Melatonin
attenuates scopolamine-induced memory/synaptic disorder by rescuing
EPACs/miR-124/Egr1 pathway. Mol Neurobiol. 47:373–381. 2013.
View Article : Google Scholar
|
30
|
Lin XZ, Luo J, Zhang LP, et al: MiR-27a
suppresses triglyceride accumulation and affects gene mRNA
expression associated with fat metabolism in dairy goat mammary
gland epithelial cells. Gene. 521:15–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chen L, Hu X, Dai Y, et al: MicroRNA-27a
activity is not suppressed in porcine oocytes. Front Biosci (Elite
Ed). 4:2679–2685. 2012. View
Article : Google Scholar
|
32
|
Fletcher CE, Dart DA, Sita-Lumsden A, et
al: Androgen-regulated processing of the oncomir miR-27a, which
targets Prohibitin in prostate cancer. Hum Mol Genet. 21:3112–3127.
2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Yoon KA, Yoon H, Park S, et al: The
prognostic impact of microRNA sequence polymorphisms on the
recurrence of patients with completely resected non-small cell lung
cancer. J Thorac Cardiovasc Surg. 144:794–807. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Hezova R, Kovarikova A, Bienertova-Vasku
J, et al: Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as
risk factors of colorectal cancer. World J Gastroenterol.
18:2827–2831. 2012. View Article : Google Scholar : PubMed/NCBI
|
35
|
Huang Z, Chen X, Yu B, He J and Chen D:
MicroRNA-27a promotes myoblast proliferation by targeting
myostatin. Biochem Biophys Res Commun. 423:265–269. 2012.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Lü MH, Li CZ, Hu CJ, et al: microRNA-27b
suppresses mouse MSC migration to the liver by targeting SDF-1α in
vitro. Biochem Biophys Res Commun. 421:389–395. 2012. View Article : Google Scholar
|